Recently, more and more studies have found that the abnormally high expression of PROX1 is related to many systemic malignant diseases such as neuroblastoma, colon cancer, kidney cancer, gastric cancer, esophageal squamous cell carcinoma and hepatocellular carcinoma. This evidence concerns the gene PROX1 and colonic neoplasm.